Scholarlink

Background <p>The detection of <i>de novo</i> synthesized mRNA transcripts is crucial for understanding the regulation of eukaryotic transcription. Using nucleoside or nucleotide analogues to label nascent RNA is potentially jeopardized by the ubiquitous presence of ribonucleotide reductase enzymes (RNRs) that can convert ribonucleotides into 2’-deoxyribonucleotides, the building blocks of DNA. Despite this challenge, the uridine analogue 5-ethynyl uridine (EU) has been commercialized and routinely used as specific label for nascent RNAs. Here, we employ confocal imaging, flow cytometry and biochemistry methods to study the specificity of EU to label RNA in six different animal species.</p> Results <p>We demonstrate that EU integrates as expected predominantly into RNA of human embryonic kidney cell line (HEK293T), the <i>Drosophila</i> wing disc and the comb jelly <i>Mnemiopsis leidyi</i>. In contrast, we found that EU predominantly labels DNA in the sea anemones <i>Nematostella vectensis</i> and <i>Exaiptasia diaphana</i>, and the polychaete <i>Platynereis dumerilii</i>. In <i>Nematostella</i>, we show that inhibiting RNR by hydroxyurea abolishes cell proliferation and the incorporation of EU into DNA. Alternative compounds for labelling nascent RNA, such as 5-ethynyl cytidine (EC), 5-ethynyl uridine triphosphate (EUTP) or 2-ethynyl adenosine (EA) show similarly low specificity for RNA in <i>Nematostella</i>.</p> Conclusions <p>Our findings raise concerns about the specificity of ethynylated nucleosides and nucleotides, including EU, to label RNA in some animals. We therefore suggest good practice guidelines help identifying unintentional DNA labelling when using EU to label nascent RNA.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The nascent RNA labelling compound 5-ethynyl uridine (EU) integrates into DNA in some animals

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月26日

查看全文
  • Malin A. Kjosavik,
  • Katherine L. P. Downham,
  • Ruth Styfhals,
  • Leonie Adelmann,
  • Marios Chatzigeorgiou,
  • Florian Raible,
  • Pawel Burkhardt,
  • Fergal O’Farrell,
  • Patrick R. H. Steinmetz,
  • Kathrin Garschall

摘要

Background

The detection of de novo synthesized mRNA transcripts is crucial for understanding the regulation of eukaryotic transcription. Using nucleoside or nucleotide analogues to label nascent RNA is potentially jeopardized by the ubiquitous presence of ribonucleotide reductase enzymes (RNRs) that can convert ribonucleotides into 2’-deoxyribonucleotides, the building blocks of DNA. Despite this challenge, the uridine analogue 5-ethynyl uridine (EU) has been commercialized and routinely used as specific label for nascent RNAs. Here, we employ confocal imaging, flow cytometry and biochemistry methods to study the specificity of EU to label RNA in six different animal species.

Results

We demonstrate that EU integrates as expected predominantly into RNA of human embryonic kidney cell line (HEK293T), the Drosophila wing disc and the comb jelly Mnemiopsis leidyi. In contrast, we found that EU predominantly labels DNA in the sea anemones Nematostella vectensis and Exaiptasia diaphana, and the polychaete Platynereis dumerilii. In Nematostella, we show that inhibiting RNR by hydroxyurea abolishes cell proliferation and the incorporation of EU into DNA. Alternative compounds for labelling nascent RNA, such as 5-ethynyl cytidine (EC), 5-ethynyl uridine triphosphate (EUTP) or 2-ethynyl adenosine (EA) show similarly low specificity for RNA in Nematostella.

Conclusions

Our findings raise concerns about the specificity of ethynylated nucleosides and nucleotides, including EU, to label RNA in some animals. We therefore suggest good practice guidelines help identifying unintentional DNA labelling when using EU to label nascent RNA.